Making up 15 to 20 percent of all breast cancer diagnoses, triple-negative breast cancer (TNBC) is often seen as a more aggressive subtype that disproportionally affects young, Black, and Latinx communities.
Despite its reputation, TNBC can still be misunderstood, which is why we’ve partnered with the Triple-Negative Breast Cancer Foundation to bring in Elaine Walsh, MB BCh BAO, PhD to answer your questions about TNBC symptoms, side-effects, and treatment options for early stage and metastatic breast cancer.
Understanding your sub-type and its treatment options will help you make the best decisions for you.
